Kobelt D, Perez-Hernandez D, Fleuter C, Dahlmann M, et al. The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by
approved MEK1 inhibitors to restrict colorectal cancer metastasis. Oncogene 2021 Jul 10. pii: 10.1038/s41388-021-01917.
PMID: 34247190